Multiple studies show major lack of public knowledge about HPV vaccine and cancer prevention
Despite the fact that the human papillomavirus (HPV) vaccine has been available in the U.S. for over 10 years and remains the only vaccine to protect against multiple types of cancer, several recent studies show that public knowledge about the vaccine and HPV’s relationship to cancer remains low.
HPV is responsible for 90% of cervical and anal cancers, and 70% of oropharyngeal (throat) cancers.
The first-generation HPV...
Research finds evidence HPV vaccine is improving herd immunity
A study from researchers at The University of Texas MD Anderson Cancer Center found that the prevalence of the types of oral human papillomavirus...
Assets and obstacles in the fight to prevent HPV-related cancers
Despite the availability of vaccines that could prevent the majority of cancers caused by the human papillomavirus (HPV), the incidence of...
Symposium to address prevention, detection and treatment of HPV-related throat cancer
This fall, experts from MD Anderson, the American Dental Association (ADA), the Centers for Disease Control and Prevention and the University of Chicago Medicine will host an educational symposium focused on the prevention, detection and management of oropharyngeal (throat) cancers caused by the human papillomavirus (HPV).
The symposium comes as a result of the novel partnership MD Anderson and the ADA established to improve oral...
HPV vaccination rates are rising, but more work remains
According to a recent report from the Centers for Disease Control and Prevention (CDC), adolescent vaccination rates for the human...
Proton therapy offers more precision, fewer side effects for head and neck cancer patients
The good news is death rates continue to decline for the most common types of cancer, including lung, colon, breast and prostate.
The...